Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Marika J. Linja"'
Autor:
Tapio Visakorpi, Olli A. Jänne, Marika J. Linja, Visa Manni, Biswajyoti Sahu, Merja A. Helenius, Kati K. Waltering
Supplementary Figure Legends 1-6 from Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71d148d6a50ca89803f41ffc14db27e7
https://doi.org/10.1158/0008-5472.22377740.v1
https://doi.org/10.1158/0008-5472.22377740.v1
Autor:
Tapio Visakorpi, Olli A. Jänne, Marika J. Linja, Visa Manni, Biswajyoti Sahu, Merja A. Helenius, Kati K. Waltering
Supplementary Tables 1-9 from Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaa9e04997412445a9a249d682c9e0af
https://doi.org/10.1158/0008-5472.22377734
https://doi.org/10.1158/0008-5472.22377734
Autor:
Tapio Visakorpi, Olli A. Jänne, Marika J. Linja, Visa Manni, Biswajyoti Sahu, Merja A. Helenius, Kati K. Waltering
Supplementary Figures 1-6 from Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d9ace04a3257e2f9eb07df8ec589994
https://doi.org/10.1158/0008-5472.22377737.v1
https://doi.org/10.1158/0008-5472.22377737.v1
Autor:
Nina N. Nupponen, Kirmo Wartiovaara, Tea Blom, Heli Fox, Hannu Haapasalo, Alexandre Angers-Loustau, Laura Kerosuo, Olli A. Jänne, Karita Peltonen, Panu E. Kovanen, Marika J. Linja
Publikováno v:
International Journal of Cancer. 123:793-800
Activating gene mutations, gene amplifications and overexpressed proteins may be useful as targets for novel therapies. Alterations at chromosome locus 4q12 are associated with gliomas and the region harbors the receptor tyrosine kinase gene KIT, whi
Autor:
Jorma J. Palvimo, Kimmo Savinainen, Olli A. Jänne, Marika J. Linja, Teuvo L.J. Tammela, Kati P. Porkka, Robert L. Vessella, Zhikang Kang, Tapio Visakorpi
Publikováno v:
Clinical Cancer Research. 10:1032-1040
Purpose: The androgen receptor (AR)-mediated signaling pathway seems to be essentially involved in the development and progression of prostate cancer. In vitro studies have shown that altered expression of AR coregulators may significantly modify tra
Autor:
Glenn T.G. Chang, Kimmo Savinainen, Teuvo L.J. Tammela, Tapio Visakorpi, Albert O. Brinkmann, Outi R. Saramäki, Marika J. Linja
Publikováno v:
British Journal of Cancer, 90, 1041-1046. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer
The long arm of chromosome 8 is one of the most common regions of amplification in cancers of several organs, especially carcinomas of the breast and prostate. TRPS1, MYC and EIF3S3 genes are located in one of the minimal regions of amplification, 8q
Publikováno v:
The Prostate. 55:180-186
BACKGROUND It has been suggested that estrogens and their receptors (ERs) may be involved in the development and progression of prostate cancer. To elucidate the significance of these receptors, expression of both ERα and ERβ was measured in benign
Autor:
Outi R. Saramäki, Teuvo L.J. Tammela, Ola Bratt, Marika J. Linja, Jorma Isola, Tapio Visakorpi, Kimmo Savinainen
Publikováno v:
The American Journal of Pathology. 160:339-345
An anti-ERBB2 antibody, trastuzumab, has been shown to be highly efficient in the treatment of metastatic breast cancers overexpressing the ERBB2 gene. It has been suggested that overexpression and even amplification of ERBB2 may play a role in the d
Autor:
Marika J. Linja, Tapio Visakorpi
Publikováno v:
The Journal of steroid biochemistry and molecular biology. 92(4)
The significance of androgens in the development of prostate cancer has been known for more than half century. During the last decade, a lot of effort has been put to study the significance of the specific nuclear receptor of the hormone, androgen re
Publikováno v:
The Prostate. 55(3)
It has been suggested that estrogens and their receptors (ERs) may be involved in the development and progression of prostate cancer. To elucidate the significance of these receptors, expression of both ERalpha and ERbeta was measured in benign and m